Other safety alerts
|
| |
| The United States: FDA warns cancer patients not to use PNC-27 products for treatment |
| |
The Food and Drug Administration (FDA) is warning consumers not to purchase or use PNC-27, a product promoted and sold through http://PNC27.com , as a treatment or cure for cancer. An FDA laboratory discovered the bacteria Variovorax paradoxus in a PNC-27 solution sample for inhalation.
Consumers who use a contaminated product are at risk for serious, potentially life-threatening infections. Consumers at higher risk include vulnerable populations, such as young children, elderly people, pregnant women, and individuals with weakened immune systems.
PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective to treat any disease, including any form of cancer. FDA has not received reports of illnesses or serious adverse events related to PNC-27.
FDA recommends patients with cancer to discuss treatment options with a licensed health care professional. Patients who have used any PNC-27 product and have concerns should contact their health care provider as soon as possible.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/DrugSafety/ucm536094.htm
In Hong Kong, the above product is not a registered pharmaceutical product. Consumers are advised not to purchase pharmaceutical product from sources (including internet) that are doubtful. They should consult healthcare professionals before using any medication for cancer treatment.
Ends/ Wednesday, January 11, 2017
Issued at HKT 13:00
|
| |
